stella
beta
Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer — Stella
Recruiting
Back to NSCLC trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
Montefiore Einstein Comprehensive Cancer Center (MECCC), The Bronx, New York
View full record on ClinicalTrials.gov